- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02593136
Home Fortification of Complementary Foods in Bihar India
March 10, 2017 updated by: Reynaldo Martorell, Emory University
Assessing Feasibility and Program Effectiveness of Home Fortification of Complementary Foods in Bihar: A Cluster Randomized Community Pilot
This study evaluates the program effectiveness of home fortification along with infant and young child feeding (IYCF) counseling as a strategy to address anemia and complementary feedings gaps in a program setting of the Integrated Family Health Initiative being implemented by CARE India (a non-profit organization) in partnership with the Government of Bihar.
The study also seeks to assess the field level worker experience with counseling and dissemination of home fortification products.
Study Overview
Status
Completed
Conditions
Detailed Description
This study evaluates the program effectiveness of home fortification along with infant and young child feeding (IYCF) counseling as a strategy to address anemia and complementary feedings gaps in a program setting of the Integrated Family Health Initiative being implemented by CARE India (a non-profit organization) in partnership with the Government of Bihar.The key objectives of this study are to examine acceptability and utilization by target population, assess impact on infant and young child feeding (IYCF) practices, evaluate impact on child growth, evaluate impact on hemoglobin concentration, and assess front line worker experience and motivation to disseminate enhanced counseling and home fortification products.
Study Type
Interventional
Enrollment (Actual)
11861
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bihar
-
Patna, Bihar, India
- CARE-India
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 1 year (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Randomly selected children living within Health-Sub Centers (HSC) in West Champaran Bihar
Exclusion Criteria:
- Children less than six months of age
- Children greater than eighteen months of age
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Home Fortification and Counseling
Participants aged 6 to 18 months will receive a daily supplement of vitamins and minerals in dry powder form to be taken once daily for up to nine months or up to 240 sachets.
Participant caregivers will also receive improved young child feeding practices (IYCF) counseling from a front line worker.
|
The home fortification product (HFP) is a sachet containing multiple vitamins and nutrients as follows: Iron (Ferrous Fumarate) 12.5 mg Zinc (Zinc Gluconate) 5 mg Folic Acid 0.160 mg Vitamin-A (Vit-A Acetate) 0.30 mg Vitamin-C (Ascorbic Acid) 30 mg Vitamin-B12 0.9 mcg Iodine 90 mcg Maltodextrin (Base)
Infant and Young Child Feeding (IYCF) Practices Counseling provides direction on breast milk and milk feeding, food variety, and frequency for caregivers of children aged 6 to 18 months.
Participants will be visited at least monthly by a field line worker for IYCF counseling and educational materials distribution.
|
Experimental: Improved Child Feeding Practices (IYCF) Counseling
Participants ages 6 to 18 months will receive improved young child feeding practices (IYCF) counseling from a front line worker.
|
Infant and Young Child Feeding (IYCF) Practices Counseling provides direction on breast milk and milk feeding, food variety, and frequency for caregivers of children aged 6 to 18 months.
Participants will be visited at least monthly by a field line worker for IYCF counseling and educational materials distribution.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of home fortification sachets consumed
Time Frame: Within 7 days (Up to 7 days)
|
The number of sachets consumed versus those received by participants within seven days of distribution.
|
Within 7 days (Up to 7 days)
|
Number of home fortification sachets consumed
Time Frame: Within 31 days (Up to 31 days)
|
The number of sachets consumed versus those received by participants within thirty one days of distribution.
|
Within 31 days (Up to 31 days)
|
Change in hemoglobin concentration
Time Frame: Baseline (month 0), Endline (month 12)
|
Hemoglobin concentration will be collected by taking a small blood sample via finger or heal prick.
A hemoglobin level below 7 g/dl is considered severe anemia.
|
Baseline (month 0), Endline (month 12)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of home visits
Time Frame: Up to 12 months
|
The number of times a front-line worker (FLW) visits one home within a twelve month period.
|
Up to 12 months
|
Frequency of home fortification sachet distribution
Time Frame: Up to twelve months
|
The number of times a front-line worker (FLW) distributes home fortification sachets within a twelve month period.
|
Up to twelve months
|
Change in body length
Time Frame: Baseline (month 0), Endline (month 12)
|
Child length will be measured using a SECA 417 length measuring board.
Its measuring range is 10-100 cm with a graduation of 1 mm.
|
Baseline (month 0), Endline (month 12)
|
Change in body weight
Time Frame: Baseline (month 0), Endline (month 12)
|
Child body weight will be measured using a SECA 874 mother-baby digital scale with capacity of 200 kg and graduation of 50 g < 150 kg > 100 g.
|
Baseline (month 0), Endline (month 12)
|
Complementary Feeding Rate
Time Frame: Month 6 (Up to six months)
|
The percent of children initiating complementary feeding at six months.
|
Month 6 (Up to six months)
|
Number of daily meals
Time Frame: Within 24 hours (Up to one day)
|
The number of meals consumed per child in one day.
|
Within 24 hours (Up to one day)
|
Quantity of food
Time Frame: Within 24 hours (Up to one day)
|
The amount of food consumed by a child per meal in the home fortification and IYCF arm versus the IYCF alone arm.
|
Within 24 hours (Up to one day)
|
Consistency of foods
Time Frame: Within 24 hours (Up to one day)
|
The type of food textures (thick versus thin) consumed within 24 hours in the home fortification and IYCF arm versus the IYCF alone arm.
|
Within 24 hours (Up to one day)
|
Diversity of foods
Time Frame: Within 24 hours (Up to one day)
|
The number of different food groups consumed in one day in the home fortification and IYCF arm versus the IYCF alone arm.
|
Within 24 hours (Up to one day)
|
Front-line worker motivation
Time Frame: Endline (Up to 9 months)
|
Front-line worker (FLW) motivation to disseminate enhanced counseling and home fortification products will be measured at the end of study by the FLW survey.
The FLW survey consists of questions regarding experience and perceived impact on work burden.
|
Endline (Up to 9 months)
|
Change Developmental Milestones Checklist-II (DMC-II)
Time Frame: Baseline (month 0), Endline (month 12)
|
Child development will be measured using the Developmental Milestones Checklist-II (DMC-II).
The DMC-II is a 75-item parent report questionnaire evaluating gross motor, fine motor, language, personal-social skill development in children who are 3 to 24 months in age.
The DMC-II has been slightly modified for this study by adding 7 items assessing cognitive development.
The exact number of items administered depends on responses to previous items and the total range of score varies.
Higher scores indicate increased development.
|
Baseline (month 0), Endline (month 12)
|
A-not-B task performance
Time Frame: Endline (month 12)
|
Child executive function will be measured by direct child assessment using the A-not-B task in children 12-18 months of age only.
Whether or not the child correctly identifies the location of a hidden toy is method of assessing development in early life.
|
Endline (month 12)
|
Elicited imitation task performance
Time Frame: Endline (month 12)
|
Child memory will be measured by direct child assessment using the Elicited imitation tasks in children 12-18 months of age only.
Elicited imitation tasks are a tool to diagnose communication deficiencies in children.
This test assesses whether or not a child can imitate the order of events of a sequence modeled by the evaluator.
|
Endline (month 12)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Keats EC, Das JK, Bhutta ZA. Micronutrient powders and diarrhoea risk in infants and young children - Authors' reply. Lancet Child Adolesc Health. 2021 Aug;5(8):e29-e30. doi: 10.1016/S2352-4642(21)00164-4. No abstract available.
- Larson LM, Young MF, Ramakrishnan U, Webb Girard A, Verma P, Chaudhuri I, Srikantiah S, Martorell R. A Cross-Sectional Survey in Rural Bihar, India, Indicates That Nutritional Status, Diet, and Stimulation Are Associated with Motor and Mental Development in Young Children. J Nutr. 2017 Aug;147(8):1578-1585. doi: 10.3945/jn.117.251231. Epub 2017 Jun 14.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2014
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
October 29, 2015
First Submitted That Met QC Criteria
October 29, 2015
First Posted (Estimate)
October 30, 2015
Study Record Updates
Last Update Posted (Actual)
March 14, 2017
Last Update Submitted That Met QC Criteria
March 10, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00065311
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anemia
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Hungary, Italy, Spain, United Kingdom
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)United Kingdom, Belgium, Netherlands, France, United States, Germany, Hungary, Italy
-
Hospital Universitario Dr. Jose E. GonzalezCompletedPernicious Anemia | Megaloblastic Anemia NosMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Aplastic Anemia | Idiopathic Aplastic Anemia | Moderate Aplastic Anemia Requiring Transfusions
-
Abdelwahed, Mai Mahmoud Mohamed, M.D.UnknownAnemia During PregnancyEgypt
-
University of California, DavisInstituto Mexicano del Seguro Social; Thrasher Research Fund; Mexican National... and other collaboratorsCompleted
-
Incyte CorporationActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)Spain, United States, Austria, Belgium, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Poland, United Kingdom
-
Peking Union Medical College HospitalRecruiting
-
Alexion PharmaceuticalsWithdrawnWarm Autoimmune Hemolytic AnemiaUnited States
Clinical Trials on Home Fortification Product (HFP)
-
Udayana UniversityCompletedNutritional Status | Growth Failure | Micronutrient Deficiency | Complementary Feeding | Linear ProgrammingIndonesia
-
Cogent Biosciences, Inc.TerminatedSolid Tumor | HER-2 Protein OverexpressionUnited States
-
University of British ColumbiaUniversity of Guelph; NCHADS - Ministry of Health of CambodiaCompletedAnemia, Iron-Deficiency | Anemia | HemoglobinopathiesCambodia
-
University of TennesseeCompleted